An electronic alert to decrease Kayexalate ordering

David E. LeafDivision of Renal Medicine, Brigham and Women’s Hospital, Boston, MA, USA; Correspondence[email protected]

Xingxing S. ChengDepartment of Medicine, Massachusetts General Hospital, Boston, MA, USA; ;Division of Nephrology, Stanford University, Palo Alto, CA, USA;

Jason L. SandersHarvard Affiliated Emergency Medicine Residency, Brigham and Women’s Hospital and Massachusetts General Hospital, Boston, MA, USA;

Mallika MenduDivision of Renal Medicine, Brigham and Women’s Hospital, Boston, MA, USA;

Gordon D. SchiffDivision of General Internal Medicine, Center for Patient Safety Research and Practice, Brigham and Women’s Hospital, Boston, MA, USA

David B. MountDivision of Renal Medicine, Brigham and Women’s Hospital, Boston, MA, USA;

Hasan BazariDepartment of Medicine, Massachusetts General Hospital, Boston, MA, USA;

show all

References

Sterns RH, Rojas M, Bernstein P, Chennupati S. Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective? J Am Soc Nephrol. 2010;21:733–735.
PubMed Web of Science ®Google Scholar
Harel Z, Harel S, Shah PS, Wald R, Perl J, Bell CM. Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: A systematic review. Am J Med. 2013;126:264. e269-224.
PubMed Web of Science ®Google Scholar
Chin HL, Wallace P. Embedding guidelines into direct physician order entry: simple methods, powerful results. Proc AMIA Symp. 1999;221–225.
PubMedGoogle Scholar
Freedberg DE, Salmasian H, Abrams JA, Green RA. Orders for intravenous proton pump inhibitors after implementation of an electronic alert. JAMA Intern Med. 2015;175:452–454.
PubMed Web of Science ®Google Scholar
Packham DK, Rasmussen HS, Lavin PT, et al. Sodium zirconium cyclosilicate in hyperkalemia. N Engl J Med. 2015;372:222–231.
PubMed Web of Science ®Google Scholar
Weir MR, Bakris GL, Bushinsky DA, et al. Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. N Engl J Med. 2015;372:211–221.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

An electronic alert to decrease Kayexalate ordering

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

An electronic alert to decrease Kayexalate ordering

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date